Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.99 - $2.91 $1,088 - $3,198
1,099 Added 10.57%
11,499 $14,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $2.27 $1,352 - $23,608
10,400 New
10,400 $22,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.